tiprankstipranks
Trending News
More News >
Sionna Therapeutics, Inc. (SION)
NASDAQ:SION
US Market

Sionna Therapeutics, Inc. (SION) Financial Statements

Compare
26 Followers

Sionna Therapeutics, Inc. Financial Overview

Sionna Therapeutics, Inc.'s market cap is currently $1.84B. The company's EPS TTM is $-0.46; its P/E ratio is -25.76; Sionna Therapeutics, Inc. is scheduled to report earnings on November 5, 2025, and the estimated EPS forecast is $-0.54. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00
Gross Profit$ -668.00K$ 0.00$ 0.00
Operating Income$ -70.56M$ -50.33M$ -41.37M
EBITDA$ -69.89M$ -49.75M$ -41.25M
Net Income$ -61.69M$ -47.26M$ -40.24M
Balance Sheet
Cash & Short-Term Investments$ 147.54M$ 38.52M$ 82.61M
Total Assets$ 185.75M$ 51.95M$ 87.37M
Total Debt$ 9.75M$ 10.48M$ 0.00
Net Debt$ -28.04M$ -28.04M$ -54.84M
Total Liabilities$ 349.46M$ 166.83M$ 157.29M
Stockholders' Equity$ -163.71M$ -114.88M$ -69.92M
Cash Flow
Free Cash Flow$ -52.81M$ -44.81M$ -37.94M
Operating Cash Flow$ -52.79M$ -43.70M$ -36.07M
Investing Cash Flow$ -126.91M$ 27.35M$ -29.26M
Financing Cash Flow$ 178.97M$ 31.00K$ 110.86M
Currency in USD

Sionna Therapeutics, Inc. Earnings and Revenue History

Sionna Therapeutics, Inc. Debt to Assets

Sionna Therapeutics, Inc. Cash Flow

Sionna Therapeutics, Inc. Forecast EPS vs Actual EPS